A co-founder and co-leader of the firm’s Psychedelics and Emerging Therapies Practice Group, Natasha advises clients on the regulatory matters inherent in new drug development. She also advises behavioral health clients on compliance matters. Natasha approaches her practice with great passion for the promise of psychedelics and other new drugs….
View more
Kimberly is a leading member of the psychedelic law practice group at Husch Blackwell. As a former research scientist for biotech startups, Kimberly has a unique perspective in the emerging area of psychedelic therapeutics. She keeps current on the academic and commercial research and drug discovery efforts in this rapidly…
View more
Karen is a founding member of the psychedelic law practice group at Husch Blackwell. With over sixteen years of experience in product liability litigation focusing on toxic products, Karen has a unique perspective in the emerging area of psychedelic therapeutics. She keeps current on the academic and commercial research and…
View more
With a passion for organizational growth, Hilary advises clients in the cannabis, healthcare, and life sciences spaces on transactions, regulatory compliance, governance matters, and other corporate needs. Hilary likes being a dealmaker: she values building collegial relationships with clients and other attorneys, and she loves helping clients create value and…
View more
Curt has developed a national healthcare practice providing transactional, regulatory and compliance guidance for hospitals, physicians and other types of healthcare providers. Curt routinely serves as outside counsel to hospitals and health systems regarding complex hospital/physician integration arrangements. He also is experienced in handling compliance and reimbursement matters, including government…
View more